Skip to content
Patron Exim logo

Patron Exim

543798 BSE
₹1.80

Close ·

View as Markdown
MCP
Close 4 Nov 2026 ₹1.80 −2.48 −57.9% 1Y
Start ₹4.28

Key Fundamentals

SMEChemicals & PetrochemicalsChemicals

Price-based figures at the close · TTM

ROCE
−2.69%
Debt to Equity
0.05
EPS (TTM)
—
Book Value
₹16.44
Market Cap
—
P/E (TTM)
—
P/B
0.11
ROE
−2.82%
Dividend Yield
0.00%
EBITDA
−₹1.10 Cr
52W High
₹4.30
52W Low
₹1.42

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

39 Weak

Data confidence 81/100

Category scores

Quality
20
Poor
Returns, margins, earnings quality 22% weight
Valuation
45
Weak
Cheap vs sector & own history 24% weight
Growth
34
Poor
Sales & profit trajectory 9% weight
Financial Health
55
Average
Solvency, leverage, coverage 9% weight
Momentum
20
Poor
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is almost debt free.
  • Stock is trading at 0.12 times its book value
  • Debtor days have improved from 239 to 63.3 days.

Weaknesses

4
  • Company has low interest coverage ratio.
  • Promoter holding is low: 20.0%
  • Company has a low return on equity of -0.30% over last 3 years.
  • Promoter holding has decreased over last 3 years: -51.2%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1171
OscillatorsNeutral171
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
44.83
Neutral
MACD (12,26,9)
−0.01
Bearish
SMA (50)
1.96
Bearish
SMA (200)
2.38
Bearish

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
3Y+23.19%
1Y−0.62%

Net profit

Net profit growth by window
3YTurned to loss
1YTurned to loss

Operating cash flow

Operating cash flow growth by window
3YOutflow narrowed by ₹20.80 Cr
1YOutflow widened by ₹2 Cr

Operating margin· change in pp

Operating margin growth by window
3Y+25.87 pp
1Y−3.93 pp

Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2022₹3.88 Cr
Mar 2023₹12.95 Cr
Mar 2024₹6.58 Cr
Mar 2025₹24.36 Cr
Mar 2026₹24.21 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2022₹0.99 Cr
Mar 2023₹1.38 Cr
Mar 2024₹0.67 Cr
Mar 2025₹0.07 Cr
Mar 2026−₹1.09 Cr

Half-yearly Results

₹ Cr
543798 half-yearly results, ₹ crore
Particulars Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales
3.88
9.46
3.5
1.26
5.32
0
24.36
23.72
0.49
Expenses
3.41
8.87
8.07
4.14
5.18
0.48
24.09
23.74
1.63
Operating Profit
0.47
0.59
−4.57
−2.88
0.14
−0.48
0.27
−0.02
−1.14
OPM %
12.11%
6.24%
−130.57%
−228.57%
2.63%
—
1.11%
−0.08%
−232.65%
Other Income
1.14
0.25
5.69
2.98
0.66
0.23
0.09
0.04
0.04
Interest
0.11
0
0
0
0
0
0
0
0
Depreciation
0.01
0
0
0
0
0
0
0
0
PBT
1.49
0.84
1.12
0.1
0.8
−0.25
0.36
0.02
−1.1
Tax %
28.86%
28.57%
28.57%
30%
26.25%
12%
11.11%
50%
0%
Net Profit
1.07
0.59
0.79
0.07
0.59
−0.28
0.32
0.01
−1.1
EPS (₹)
—
0.39
0.34
0.03
0.25
−0.12
0.14
0
−0.47

Profit & Loss

₹ Cr
543798 profit and loss, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
3.88
12.95
6.58
24.36
24.21
Expenses
3.41
16.92
9.33
24.57
25.37
Operating Profit
0.47
−3.97
−2.75
−0.21
−1.16
OPM %
12.11%
−30.66%
−41.79%
−0.86%
−4.79%
Other Income
1.14
5.93
3.65
0.32
0.09
Interest
0.19
0
0
0
0.01
Depreciation
0.01
0.01
0
0
0
PBT
1.41
1.95
0.9
0.11
−1.08
Tax %
30.5%
29.23%
25.56%
36.36%
0.93%
Net Profit
0.99
1.38
0.67
0.07
−1.09
EPS (₹)
—
0.6
0.29
0.03
−0.47
Div. Payout %
0%
0%
0%
0%
0%

Balance Sheet

₹ Cr
543798 balance sheet, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
5.34
23.18
23.18
23.18
23.18
Reserves
0
15.29
15.96
16.03
14.94
Borrowings
0
0.03
0.26
0.23
2.09
Other Liabilities
5.62
−0.02
5.93
4.81
8.5
Total Liabilities
10.96
38.48
45.33
44.25
48.71
Fixed Assets
0.01
0.01
0.01
0.01
0.04
CWIP
0
0
0
0
0
Investments
0
8.67
8.67
8.76
8.84
Other Assets
10.95
29.8
36.65
35.48
39.83
Total Assets
10.96
38.48
45.33
44.25
48.71

Cash Flow

₹ Cr
543798 cash flow, annual, ₹ crore
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0.76
−22.81
−0.26
−0.01
−2.01
Investing
0
−8.68
0
0
−0.04
Financing
−0.76
31.78
0.23
−0.03
1.86
Net Cash Flow
0
0.29
−0.04
−0.04
−0.19
Free Cash Flow
0.76
−22.82
−0.26
−0.01
−2.05
CFO/EBITDA
253
560
1
−14
172

Ratios

543798 financial ratios, annual
Particulars Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
710
394
562
91.55
63.32
Inventory Days
337
89.82
309
42.61
14.84
Days Payable
537
—
625
61.07
104
Cash Conversion Cycle
510
—
245
73.09
−26.15
Working Capital Days
500
831
1,675
453
440
ROCE %
—
8.9%
2.31%
0.28%
−2.69%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Patron Exim insights

49 extracted metrics across FY22–FY26.

Shareholding Pattern

As of Mar 2026

  • Public 65.47%
  • Promoters 20.03%
  • Others 14.50%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Patron Exim

What does Patron Exim Ltd do?
Incorporated in 1992, Patron Exim Ltd is in the business of trading pharma products and commission agent in pharma products, etc.
Where is Patron Exim Ltd (PATRON) listed?
Patron Exim Ltd trades under code 543798 on the BSE.
Which sector does Patron Exim Ltd belong to?
Patron Exim Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the 52-week high and low of Patron Exim Ltd?
Over the last 52 weeks Patron Exim Ltd has traded between ₹1.42 and ₹4.3 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Patron Exim Ltd?
Patron Exim Ltd reported a return on equity of -2.82%. Its debt-to-equity ratio is 0.05.

Company Information

Incorporated in 1992, Patron Exim Ltd is in the business of trading pharma products and commission agent in pharma products, etc.

Website patronexim.com
Listed 6 Mar 2023
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543798.md for Patron Exim Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month